OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Wenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 845-855
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 60

Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 38

Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 15

Long COVID and SARS-CoV-2 persistence: new answers, more questions
Danilo Buonsenso, Kelan G. Tantisira
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 796-798
Open Access | Times Cited: 8

Early biological markers of post-acute sequelae of SARS-CoV-2 infection
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Emerging SARS-CoV-2 Resistance After Antiviral Treatment
Trevor J M Tamura, Manish C. Choudhary, Rinki Deo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435431-e2435431
Open Access | Times Cited: 6

Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
Maria Alfreda Stincarelli, Isabella Abbate, Giulia Matusali, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 126-126
Open Access

Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology—A Narrative Review
Orlando Guntinas‐Lichius, Thomas Bitter, Robert P. Takes, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 506-506
Open Access

Animal Models of Non-Respiratory, Post-Acute Sequelae of COVID-19
Abigail Vanderheiden, Michael Diamond
Viruses (2025) Vol. 17, Iss. 1, pp. 98-98
Open Access

Viral burden and illness severity during acute SARS-CoV-2 infection predict persistent long COVID symptoms
Elisabeth Brandstetter, Anne Frosch, Kristina S. Burrack, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 2
Open Access

Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access

Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants
Shijie Qin, Yanan Zhang, Yanhua Li, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101218-101218
Open Access | Times Cited: 5

Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2-Omicron infection: a retrospective cohort study
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 10, pp. 1319-1326
Closed Access | Times Cited: 3

SARS-CoV-2 S1 subunit produces a protracted priming of the neuroinflammatory, physiological, and behavioral responses to a remote immune challenge: A role for corticosteroids
Matthew G. Frank, Jayson B. Ball, Shelby Hopkins, et al.
Brain Behavior and Immunity (2024) Vol. 121, pp. 87-103
Closed Access | Times Cited: 3

The enduring effect of the COVID-19 pandemic on diabetes
Ziyad Al‐Aly, Bin Cao
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 8, pp. 508-510
Closed Access | Times Cited: 2

Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro
Manoj S. Nair, Maria I. Luck, Yaoxing Huang, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 2

Autoimmune Sequelae After Delta or Omicron Variant SARS-CoV-2 Infection in a Highly Vaccinated Cohort
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2430983-e2430983
Open Access | Times Cited: 2

SARS-CoV-2 antivirals and post-COVID-19 condition
Ziyad Al‐Aly
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 2

Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity
Ke Lin, Jian‐Peng Cai, Jingxin Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Post-Acute Sequelae of COVID (PASC or Long COVID): An Evidenced-based Approach
Daniel O. Griffin
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 9
Open Access | Times Cited: 1

Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function
Shokrollah Elahi, Maryam Rezaeifar, Mohammed Osman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Gastrointestinal manifestations of long COVID
Louise R King
Life Sciences (2024), pp. 123100-123100
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top